BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18290772)

  • 1. Assessment of in vivo 1H magnetic resonance spectroscopy in the liver: a review.
    Fischbach F; Bruhn H
    Liver Int; 2008 Mar; 28(3):297-307. PubMed ID: 18290772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
    Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
    Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-field proton MRS of human brain.
    Di Costanzo A; Trojsi F; Tosetti M; Giannatempo GM; Nemore F; Piccirillo M; Bonavita S; Tedeschi G; Scarabino T
    Eur J Radiol; 2003 Nov; 48(2):146-53. PubMed ID: 14680905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo phenotyping of the ob/ob mouse by magnetic resonance imaging and 1H-magnetic resonance spectroscopy.
    Calderan L; Marzola P; Nicolato E; Fabene PF; Milanese C; Bernardi P; Giordano A; Cinti S; Sbarbati A
    Obesity (Silver Spring); 2006 Mar; 14(3):405-14. PubMed ID: 16648611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of intrahepatic lipids by 1H-MRS--studies by breath-holding & 1 cm3 VOI].
    Choji T; Honjou K; Suda H; Hatanaka M; Sasai K; Homma Y; Itoh K; Suga K; Nakanishi T; Kimura T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jan; 52(1):107-9. PubMed ID: 1549441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR proton spectroscopy in liver examinations of healthy individuals in vivo.
    Tarasów E; Siergiejczyk L; Panasiuk A; Kubas B; Dzienis W; Prokopowicz D; Walecki J
    Med Sci Monit; 2002 Feb; 8(2):MT36-40. PubMed ID: 11859290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRS quality assessment in a multicentre study on MRS-based classification of brain tumours.
    van der Graaf M; Julià-Sapé M; Howe FA; Ziegler A; Majós C; Moreno-Torres A; Rijpkema M; Acosta D; Opstad KS; van der Meulen YM; Arús C; Heerschap A
    NMR Biomed; 2008 Feb; 21(2):148-58. PubMed ID: 17458918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR spectroscopy in clinical research.
    Henriksen O
    Acta Radiol; 1994 Mar; 35(2):96-116. PubMed ID: 8172753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of musculoskeletal tumors by proton MR spectroscopy.
    Fayad LM; Barker PB; Bluemke DA
    Semin Musculoskelet Radiol; 2007 Sep; 11(3):240-5. PubMed ID: 18260034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the specific absorption rate and calibration of decoupling parameters for proton decoupled carbon-13 MR spectroscopy at 3.0 T.
    Saito M; Matsuda T; Tropp J; Inubushi T; Nakai T
    Eur J Radiol; 2005 Aug; 55(2):289-93. PubMed ID: 16036162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts.
    Kreis R
    NMR Biomed; 2004 Oct; 17(6):361-81. PubMed ID: 15468083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations in applying 3D PRESS H-1 brain MRSI with an eight-channel phased-array coil at 3 T.
    Li Y; Osorio JA; Ozturk-Isik E; Chen AP; Xu D; Crane JC; Cha S; Chang S; Berger MS; Vigneron DB; Nelson SJ
    Magn Reson Imaging; 2006 Dec; 24(10):1295-302. PubMed ID: 17145400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of proton MR for the study of muscle lipid metabolism.
    Boesch C; Machann J; Vermathen P; Schick F
    NMR Biomed; 2006 Nov; 19(7):968-88. PubMed ID: 17075965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Localized nuclear magnetic resonance spectroscopy in vivo. Physical principles and quantitative problems].
    Canese R; Podo F
    Ann Ist Super Sanita; 1991; 27(4):675-708. PubMed ID: 1820740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [No-invasive determination of liver fat with 1H-MR spectroscopy].
    van Werven JR; Nederveen AJ; Stoker J
    Ned Tijdschr Geneeskd; 2011; 155():A2756. PubMed ID: 21418702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications.
    Khan SA; Cox IJ; Hamilton G; Thomas HC; Taylor-Robinson SD
    Liver Int; 2005 Apr; 25(2):273-81. PubMed ID: 15780050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of breast cancer using two-dimensional MRS.
    Thomas MA; Lipnick S; Velan SS; Liu X; Banakar S; Binesh N; Ramadan S; Ambrosio A; Raylman RR; Sayre J; DeBruhl N; Bassett L
    NMR Biomed; 2009 Jan; 22(1):77-91. PubMed ID: 19086016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measurement of intrahepatic triglyceride stores by 1H magnetic resonance spectroscopy: study with rat models and in patients].
    Liu M; Gao X; Rao SX; Wu L; Zeng MS
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):531-3. PubMed ID: 18649768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical magnetic resonance spectroscopy: feasibility and methods using whole body tomographs].
    Wicklow K; Kolem H; Schneider M; Sauter R
    Aktuelle Radiol; 1993 Mar; 3(2):90-9. PubMed ID: 8476957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.